Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 30Merck Canada Inc.

02 24Schering-Plough Canada Inc.

03 8Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Interferon Alfa-2B

Brand Name : UNITRON PEG

Patent Number : 2329474

Filing Date : 1996-10-31

Strength per Unit : 67.5 ug / Redipen

Dosage Form : Powder for Solution for Injection

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2016-10-31

Date Granted : 2002-02-26

blank

02

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Interferon Alfa-2B

Brand Name : UNITRON PEG

Patent Number : 2324467

Filing Date : 1999-03-24

Strength per Unit : 67.5 ug / Redipen

Dosage Form : Powder for Solution for Injection

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2019-03-24

Date Granted : 2002-11-05

blank

03

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Interferon Alfa-2B

Brand Name : UNITRON PEG

Patent Number : 2268433

Filing Date : 1998-12-16

Strength per Unit : 67.5 ug / Redipen

Dosage Form : Powder for Solution for Injection

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2018-12-16

Date Granted : 2002-07-30

blank

04

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Interferon Alfa-2B

Brand Name : UNITRON PEG

Patent Number : 2288038

Filing Date : 1998-04-28

Strength per Unit : 67.5 ug / Redipen

Dosage Form : Powder for Solution for Injection

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2018-04-28

Date Granted : 2003-07-29

blank

05

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Interferon Alfa-2B

Brand Name : UNITRON PEG

Patent Number : 2329474

Filing Date : 1996-10-31

Strength per Unit : 108 ug / Redipen

Dosage Form : Powder for Solution for Injection

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2016-10-31

Date Granted : 2002-02-26

blank

06

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Interferon Alfa-2B

Brand Name : UNITRON PEG

Patent Number : 2324467

Filing Date : 1999-03-24

Strength per Unit : 108 ug / Redipen

Dosage Form : Powder for Solution for Injection

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2019-03-24

Date Granted : 2002-11-05

blank

07

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Interferon Alfa-2B

Brand Name : UNITRON PEG

Patent Number : 2268433

Filing Date : 1998-12-16

Strength per Unit : 108 ug / Redipen

Dosage Form : Powder for Solution for Injection

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2018-12-16

Date Granted : 2002-07-30

blank

08

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Interferon Alfa-2B

Brand Name : UNITRON PEG

Patent Number : 2288038

Filing Date : 1998-04-28

Strength per Unit : 108 ug / Redipen

Dosage Form : Powder for Solution for Injection

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2018-04-28

Date Granted : 2003-07-29

blank

09

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Interferon Alfa-2B

Brand Name : UNITRON PEG

Patent Number : 2329474

Filing Date : 1996-10-31

Strength per Unit : 135 ug / Redipen

Dosage Form : Powder for Solution for Injection

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2016-10-31

Date Granted : 2002-02-26

blank

10

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

Interferon Alfa-2B

Brand Name : UNITRON PEG

Patent Number : 2324467

Filing Date : 1999-03-24

Strength per Unit : 135 ug / Redipen

Dosage Form : Powder for Solution for Injection

Human Or VET : Human

Route of Administration : Subcutaneous Injection

Patent Expiration Date : 2019-03-24

Date Granted : 2002-11-05

blank